We inspire the scientific community by
revealing new gateways in drug R&D
Data science is revealing new ways to understand disease and pointing to promising, new therapeutic interventions. Researchers need a way to unlock new gateways in drug discovery to accelerate their R&D efforts. By tapping into our extensive network of thought leaders and harnessing more than 50 years of experience in scientific knowledge management, we are able to identify emerging trends in biomedical research and show how data science is enabling a new paradigm, transforming patient care.
We empower and accelerate
biomedical research by developing
unique data science solutions
Our advanced data analytics solutions address the challenges of molecular and biological complexity in drug discovery. We connect emerging data sources and life science content into advanced knowledge management platforms that deliver meaningful biomedical intelligence.
We support and invest in early stage,
life science initiatives that share our vision
We invest and partner with academic research teams and startups pioneering innovative uses of data in the life sciences that align with our technologies and capabilities.
NEW MATERIAL TRANSFER AGREEMENT (MTA) BETWEEN THE FDA AND BIOINFOGATE TO ACCESS THE OFF-X TRANSLATIONAL SAFETY INTELLIGENCE PORTAL